Together-Breast Cancer Support Platform
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Breast Cancer, Breast Cancer Survivors. Basic parameters: from 18 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
"Together": A Bilingual Online Platform Support Intervention Project for Korean Breast Cancer Survivors
Overview
The goal of this study is to evaluate the acceptability and engagement of a culturally tailored online peer-support program for Korean speaking breast cancer patients and survivors. The main questions it aims to answer are: 1) Is the peer-support program acceptable and sustainable in terms of engagement between mentors and mentees over a 12-week period? 2) Does participation in the program improve quality of life, psychological well-being (including anxiety and depression), and perceived social support? Participants will include Korean speaking breast cancer survivors (mentors) and patients currently undergoing treatment (mentees). After enrollment and matching based on screening information, participants will engage in peer-support interactions through an online platform for 12 weeks. Surveys will be administered at baseline, mid-point, post-intervention, and optional 6-month follow-up to assess outcomes.
Detailed description
This study evaluates the acceptability and engagement of a culturally tailored online peer-support program for Korean speaking breast cancer patients and survivors, as well as its potential impact on psychosocial outcomes.
A total of 24 participants will be enrolled, including 8 mentors (breast cancer survivors diagnosed at least two years prior who have completed active treatment or are on long-term maintenance therapy) and 16 mentees (patients currently undergoing treatment).
Participants will be recruited through community outreach using study flyers with a QR code that links to an online eligibility screener. Individuals who complete the screener will be contacted by the study coordinator to confirm eligibility and complete the informed consent process prior to enrollment.
Mentors and mentees will be matched based on information collected from the screener, including demographic and clinical characteristics such as age group and cancer stage at diagnosis. Each mentor may be matched with up to two mentees.
Mentors will complete a structured training program prior to participation. All participants will engage in peer-support interactions through an online platform over a 12-week period, with a minimum expectation of at least one bidirectional interaction per week.
Data will be collected using REDCap. Participants will complete surveys at baseline, mid-intervention (weeks 4-5), and post-intervention (weeks 12-13), with an optional follow-up survey at 6 months.
Outcome measures include engagement metrics, quality of life, psychological well-being (including anxiety and depression), and perceived social support.
Primary outcome measures
- Feasibility of peer-support platform engagement [Time frame: Week 1 to Week 12]
Secondary outcome measures (3)
- Change in quality of life (FACT-B score) [Time frame: Baseline to Week 12]
- Change in social/family well-being (FACT-B social/family subscale) [Time frame: Baseline to Week 12]
- Change in self-efficacy score [Time frame: Baseline to Week 12]
Eligibility criteria
Inclusion criteria
Mentors:
- Age ≥ 18 years
- Self-identify as Korean
- Able to read, write, and speak both Korean and English
- Diagnosed with breast cancer ≥ 2 years prior to enrollment
- Completed active treatment or currently on long-term maintenance therapy
- Access to a smartphone, computer, or similar device compatible with the study platform
- Willing to participate for at least 3 months
- Willing to complete required training and surveys
Mentees:
- Age ≥ 18 years
- Self-identify as Korean
- Able to read, write, and speak Korean
- Diagnosed with breast cancer
- Currently receiving treatment (e.g., chemotherapy, radiation therapy, recent surgery, or endocrine therapy)
- Access to a smartphone, computer, or similar device compatible with the study platform
- Willing to participate for at least 3 months
- Willing to complete required surveys
Exclusion criteria
- Individuals who do not meet the inclusion criteria
- Individuals unable to use the online platform or required technology
- Individuals deemed non-compliant or inappropriate for participation based on investigator judgment (e.g., inability to complete study procedures)
- Mentees diagnosed with ductal carcinoma in situ (DCIS)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- Cedars Siani Cancer — Los Angeles
Identifiers
NCT: NCT07499089 · Study00003360